Abiopharma

News list

Director Newcomer Mark 🔴 sold 150.0K shares of Paysign, Inc. (PAYS) at $11.88 ($1.8M) Transaction Date: Aug 06, 2026 | Filing ID: 006116

Full text

News bot Aug. 8, 2026, 12:04 a.m.
🔍 Newcomer Mark (Director)

Company: Paysign, Inc. (PAYS)

Report Date: 2026-08-06
Transaction Summary:
- Total transactions: 1
- Derivative instruments: 0
- Holdings reported: 0
- Total shares sold: 150,000
Detailed Transactions and Holdings:
- Sold 150,000 shares of Common Stock at $11.8757 per share (Direct)
  Date: 2026-08-06 | Code: S | equity_swap_involved: 0 | shares_owned_after: 9,163,002.00 | transaction_form_type: 4 | Footnotes: F1, F2
Footnotes:
- F1: Transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 12, 2025.
- F2: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $11.2444 to $12.4641, inclusive. The reporting person undertakes to provide Paysign, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.